Search

Search Constraints

You searched for: Author/Creator Tsubata, Yukari

Search Results

11. Immune checkpoint inhibitor (ICI)-induced hepatitis diagnosed by liver biopsy followed by ICI-free chemotherapy leading to therapeutic effect: A case of lung cancer treatment. (2022)

12. Impact of HER2 expression on EGFR-TKI treatment outcomes in lung tumors harboring EGFR mutations: A HER2-CS study subset analysis. (December 2020)

13. Incidence of venous thromboembolism in advanced lung cancer and efficacy and safety of direct oral anticoagulants: a multicenter, prospective, observational study (Rising-VTE/NEJ037 study). (July 2022)

15. Novel prospective umbrella‐type lung cancer registry study for clarifying clinical practice patterns: CS‐Lung‐003 study protocol. Issue 5 (12th January 2021)

16. Osimertinib versus osimertinib plus chemotherapy for non–small cell lung cancer with EGFR (T790M)-associated resistance to initial EGFR inhibitor treatment: An open-label, randomised phase 2 clinical trial. (May 2021)

18. Pharmacokinetic study of the oral fluorouracil antitumor agent S‐1 in patients with impaired renal function. Issue 6 (11th May 2019)

20. Prospective clinical trial evaluating vulnerability and chemotherapy risk using geriatric assessment tools in older patients with lung cancer. Issue 11 (20th November 2019)